798 – Efficacy and Safety of Open-Label Treatment with Tofacitinib 10 Mg Twice Daily in Patients with Ulcerativ Ecolitis with Clinical Response, But Not Remission, After 52 Weeks of Maintenance Therapy: Data from the Octave Studies